1Northway WH Jr,Rosan RC,Porter DY.Pulmonary disease following respirator therapy of hyaline membrane disease.Bronchopulmonary dysplasia[J].N Engl J Med,1967,276(7):357-368.
2Fanaroff AA,Stoll BJ,Wright LL,et al.Trends in neonatal morbidity and mortality for very low birthweight infants[J].Am J Obstet Gynecol,2007,196(2):147.e1-147.e8.
3Bartholomew J,Kovacs L,Papageorgiou A.Review of the antenatal and postnatal use of steroids[J].Indian J Pediatr,2014,81(5):466-472.
4Grier DG,Halliday HL.Corticosteroids in the prevention and management of bronchopulmonary dysplasia[J].Semin Neonatol,2003,8(1):83-91.
6Committee on Fetus and Newborn Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants[J].Paediatrics,2002,109(2):330-338.
7Jefferies AL.Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants[J].Paediatr Child Health,2012,17(10):573-574.
8Shinwell ES,Lerner-Geva L,Lusky A,et al.Less postnatal steroids,more bronchopulmonary dysplasia:a population-based study in very low birthweight infants[J].Arch Dis Child Fetal Neonatal Ed,2007,92(1):F30-F33.
10Wang YC,Tseng HI,Yang SN,et al.Effects of antenatal corticosteroids on neonatal outcomes in very-low-birth-weight preterm newborns:a 10-year retrospective study in a medical center[J].Pediatr Neonatol,2012,53(3):178-183.
同被引文献99
1邵肖梅,叶鸿瑁,丘小汕.实用新生儿学.第4版.北京:人民卫生出版社,2011.
2Shah VS, Ohlsson A, Halliday HL, et al. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev, 2012,5: CD001969.
3Yeh TF, Lin HC, Chang CH, et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics, 2008,121(5): el310-el318.
4Bassler D, Plavka R, Shinwell ES, et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia.N Engl J Med, 2015,373( 16): 1497-1506.
5Jdnsson B, Eriksson M, Soder 0, et al. Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease. Acta Paediatr, 2000, 89( 12): 1449-1455.
6Kovacs L, Davis GM, Faucher D, et al. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatr, 1998,87(7): 792-798.
7Merz U, Kusenbach G, Hausler M, et al. Inhaled budesonide in ventilator-dependent preterm infants: A randomized, double-blind pilot study. Biol Neonate, 1999, 75( 1): 46-53.
8Yeh TF, Chen CM, Wu SY, et al. Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Am J Respir Crit Care Med,2016,193(1):86-95.
9Halliday HL, Patterson CC, Halahakoon CW. A multicenter, randomized open study of early corticosteroid treatment(OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics, 2001,107(2): 232-240.
